Medical Device Procurement Checklist: 7 Steps Before You Sign Anything

Who this checklist is for

If you're staring down a capital equipment cycle, replacing a failed infusion pump before the weekend, or being asked to "just get quotes" for a tracheostomy tube line, this is the checklist I use. Seven steps, in order. I've run it on everything from $4,000 syringe pumps to seven-figure imaging suites, and the logic doesn't change much: it forces you to compare total cost instead of sticker price.

Context on me: I'm a procurement manager at a 380-bed regional hospital system. I've managed our capital and consumable device budget (roughly $6.4M annually) for nine years, negotiated with 40+ device vendors, and logged every purchase order in our ERP since 2016. I'm not a clinician and I'm not an engineer—more on that boundary later.

Here are the seven steps. The one most people skip is Step 2, and it's usually the most expensive mistake.

Step 1: Write the clinical requirement before you open a catalog

Start with a one-page requirement document signed by the clinical owner. Not a product name—a requirement. "We need to replace 12 syringe pumps in ICU with units that support our current drug library and can be integrated with the EMR" is a requirement. "We need Medfusion pumps" is a brand preference dressed up as a requirement. Those are different documents, and only one of them survives an audit.

Quick definition break here, because this trips up people who don't buy imaging: a medical imaging system is any device that produces visual representations of the inside of the body—X-ray, CT, MRI, ultrasound, mammography. An endoscope is a different animal: an instrument that goes into the body (GI tract, airway, joints) with a camera and light source for direct visualization, and often intervention. So if you're asking "what is medical imaging" versus what an endoscope is, the practical answer for procurement is this—imaging systems are capital assets with software subscriptions, radiation safety requirements, and room-level infrastructure costs. Endoscopes are reusable instruments with reprocessing workflows and notoriously high repair frequency. Your evaluation criteria are not the same, and your TCO model shouldn't be either.

Checkpoint: one page, signed, with the clinical owner's name on it. If you can't get that signature, you're not ready to go to market.

Step 2: Map the consumable ecosystem (the step most buyers skip)

Here's the part that gets people. An infusion pump is not a standalone device. Neither is a tracheostomy tube.

When you buy a Medfusion pump, your consumables are the dedicated syringe sets. When you standardize on Smiths Medical Bivona tracheostomy tubes, you're choosing a specific product family with its own sizing, cuff options, and accessory line. That's not a red flag by itself—it's how most device ecosystems work, and it's often how manufacturers fund their clinical support. But you need to price it before you sign, not after.

Ask every vendor three questions in writing:

• What is the annual consumable cost per unit at our projected volume?
• Can we use third-party consumables without voiding warranty or training coverage?
• What is your contractual cap on consumable price increases, and over what term?

On our pump fleet, consumables ran about 60% of five-year total cost. Sixty percent. The device price was almost a rounding error next to the tube sets. If your RFP only asks for unit price, you're comparing the wrong number and you'll find out in year three.

Checkpoint: a five-year consumable estimate per vendor, in writing, with the increase cap documented.

Step 3: Demand a TCO quote, not a unit price

Total cost of ownership, itemized. Not "all-inclusive"—itemized, because the whole point is seeing what's inside the bundle. Ask for:

• Base device price, per unit
• Installation and commissioning (imaging systems can carry six figures here—room shielding, power, HVAC)
• Initial and refresher clinical training, priced separately
• Warranty term, and the cost to extend it
• Preventive maintenance and calibration contract, annual
• Software licensing or subscription, annual
• End-of-life disposal or trade-in credit

Two years ago I audited our 2022 device spending and found that 17% of our "budget overruns" came from maintenance contracts that renewed automatically at 8% annual escalation, buried in a schedule nobody read. We now require every contract to state the renewal escalation rate on the signature page. That one policy change cut our overrun rate by more than half.

Checkpoint: a filled TCO spreadsheet, same line items across all vendors, five-year horizon.

Step 4: Verify regulatory status and recall history

For anything entering your formulary or capital plan, pull the FDA 510(k) clearance number and confirm the cleared indications match your actual use case. Then check the FDA's MAUDE database for adverse event reports on the specific model, not just the manufacturer. A clean corporate record and a messy product-line record can coexist.

Also confirm UDI labeling and that the device is on your recall-alert distribution list before it ships. This is basic, but I've seen a 300-bed facility take delivery of a device that had a Class II recall issued two weeks earlier because nobody was monitoring.

Checkpoint: clearance number, cleared indication, and a MAUDE pull printed for the file.

Step 5: Pressure-test the service network, not the sales pitch

Every vendor claims a global service network. Ask for the address of the nearest field service engineer and the contractual response time for your zip code. Then ask what happens on a Friday night in February.

This is where a broad portfolio and a real service footprint actually matter. If a vendor can support your infusion pumps, airway products, and monitoring equipment under one service agreement, that's fewer contract lines to manage and one fewer number to call at 2 a.m. It's also more leverage at renewal—but only if the response times are in writing.

Checkpoint: written response-time commitment by severity tier, plus a named service contact.

Step 6: Run a scored trial with your own clinicians

Never buy a device that hasn't been in your clinicians' hands. This applies double to tracheostomy tubes and endoscopes, where the difference between two products with identical specs is often in the feel, the cuff inflation, the visualization, or the reprocessing workflow.

One thing I'd flag from the procurement side: clinical staff judge your department by the equipment you hand them, and patients notice too—they may not know what a syringe pump does, but they know when something looks like it came from 1998. That perception is part of your institution's reputation, and it's worth a column in your evaluation. That said, this isn't an argument for buying the most expensive option on the sheet. It's an argument for not letting price be the only column.

I'm not a clinician, so I can't tell you which cuff pressure protocol is right for your patient population or which scope gives the best image. What I can tell you is how to make the feedback comparable: same scorecard, same scenarios, same raters, scored independently, before any price data is shared with the clinical team.

Checkpoint: a scored trial sheet from at least five clinicians, completed blind to pricing.

Step 7: Lock down supply continuity and exit terms

Two years ago I had 36 hours to commit to a ventilator order or lose the fiscal-year allocation. Normally I'd run three quotes and a trial. Instead I went with our incumbent on trust and a verbal delivery commitment. In hindsight, I should have pushed finance for a carryover—it worked out, but "it worked out" is not a procurement strategy.

So write the boring clauses:

• Guaranteed allocation percentage during shortage events
• Price protection term and index for consumables
• Exit and transition assistance (data export, training on the replacement, buyback)
• Notice period, and what survives termination

I have mixed feelings about sole-source standardization. On one hand, fewer SKUs mean less training burden and better pricing leverage. On the other, we got through the 2021 supply crunch because we had two approved tracheostomy tube vendors, and the backup saved us from a three-week stockout. My compromise: primary supplier, plus one qualified backup with a small standing order to keep the relationship and the approval current.

Checkpoint: signed contract with allocation, price protection, and exit clauses reviewed by legal.

Common mistakes, and what they actually cost

Comparing unit price only. This is the expensive one. On pumps, the device is the cheap part. The bottom line lives in the consumables contract.

Assuming training is included. It usually is—for the first cohort, at the main campus. Add travel and backfill for satellite sites and the number changes.

Skipping the trial to save a month. You'll spend that month in year two, on remediation, with worse options.

Not checking the region's service coverage. A great device with a four-day response time in your area is a liability, not an asset. This is a deal-breaker, not a negotiation point.

Forgetting the reprocessing workflow. For endoscopes and reusable airway instruments, the cost of reprocessing can exceed the device cost over its life. Put it in the TCO or you're guessing.

If you've ever signed a device contract and then discovered a line item three years later, you know the feeling. Run the seven steps. It takes an extra two weeks and it's a no-brainer against a five-year commitment.